Screener
Biote Corp. BTMD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 68.6%-3.4pp | 70.1%-1.2pp | 71.5%+0.9pp | 72.4%+2.5pp | 72%+2.4pp | |
| Operating margin | 8%-9.7pp | 15.4%-0.1pp | 18.5%+2.5pp | 16.1%-1.7pp | 17.8%+1.9pp | |
| Net margin | 3.2%-12.5pp | 8.3%-2.3pp | 14.1%+12.5pp | 14.7%+11.0pp | 15.7%+13.6pp | |
| Returns | ||||||
| Return on invested capital | 37.1%— | —— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.8×-0.2× | 1.8×+0.4× | 1.7×+0.3× | 1.8×+0.3× | 2×+0.4× | |
| Liquidity | ||||||
| Current ratio | 1.4×+0.5× | 1.3×-0.1× | 1.2×-0.1× | 1×-0.5× | 1×-0.4× | |
| Leverage | ||||||
| Net debt / EBITDA | 6.3×+4.1× | 3×+1.0× | 2.1×0.0× | 2.2×+0.3× | 2.3×-0.3× | |
| Per Share | ||||||
| Book value per share | -$2.30+14.3% | -$1.56+36.0% | -$1.60+48.3% | -$1.98+50.9% | -$2.68+38.1% | |
| Valuation | ||||||
| Market capitalization | $44.45M-58.3% | $41.46M-60.5% | $79.77M-58.5% | $95.08M-45.0% | $125.63M-44.5% | |
| Price / earnings | 7.6×+4.2× | 2.7×-2.3× | 2.9×-58.0× | 3.3×-20.8× | 4×-52.4× | |
| Price / sales | 0.2×-0.3× | 0.2×-0.3× | 0.4×-0.6× | 0.5×-0.4× | 0.6×-0.6× | |
| EV / EBITDA | 8.7×+3.7× | 4.3×-0.7× | 4.1×-3.4× | 4.9×-1.5× | 5.5×-3.9× | |
| Dividend yield | 2.6%+0.6pp | 3.5%-1.6pp | 2.2%-0.3pp | 1.8%-1.6pp | 1.7%-1.1pp |
FAQ
- What are Biote Corp.'s profit margins?
- Biote Corp. (BTMD) runs a 68.6% gross margin and a 8.0% operating margin, with a 3.2% net margin.
- Where do Biote Corp.'s ratios come from?
- Every ratio is computed from Biote Corp.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
